Impact of sex, race and socioeconomic status on survival after pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension

被引:6
|
作者
Su, Austin Y. [1 ]
Vinogradsky, Alice [1 ]
Wang, Amy S. [1 ]
Ning, Yuming [2 ]
Abrahams, Elizabeth [3 ]
Bacchetta, Matthew [4 ,5 ]
Kurlansky, Paul [1 ]
Rosenzweig, Erika B. [3 ]
Takeda, Koji [1 ]
机构
[1] Columbia Univ, Dept Surg, Div Cardiothorac & Vasc Surg, Med Ctr, New York, NY 10032 USA
[2] Columbia Univ, Ctr Innovat & Outcomes Res, Dept Surg, New York, NY 10032 USA
[3] Columbia Univ, Dept Pediat, Div Pediat Cardiol, Med Ctr, New York, NY 10032 USA
[4] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN USA
[5] Vanderbilt Univ, Med Ctr, Dept Cardiac Surg, Nashville, TN USA
关键词
Pulmonary thromboendarterectomy; Chronic thromboembolic pulmonary hypertension; Socioeconomic status; Distressed communities index; Outcome disparities; ETHNICITY;
D O I
10.1093/ejcts/ezac364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Pulmonary thromboendarterectomy (PTE) is a definitive treatment for chronic thromboembolic pulmonary hypertension. Demographic-based disparities in PTE outcomes have not been well-studied. METHODS: We reviewed all patients who underwent PTE for chronic thromboembolic pulmonary hypertension between 2009 and 2019 at our institution, tracking demographic information including self-identified race, preoperative characteristics and 2-year survival. Socioeconomic status was assessed using the zip code-linked Distressed Communities Index, a validated holistic measure of community well-being. Survival was estimated using Kaplan-Meier method and factors associated with mortality were estimated using Cox regression. RESULTS: Of 235 PTE patients, 101 (42.9%) were white and 87 (37.0%) were black. White patients had a higher median age at surgery (57 vs 51 years, P = 0.035) and a lower degree of economic distress (33.6 vs 61.2 percentile, P < 0.001). Regarding sex, 106 (45.1%) patients were male and 129 (53.6%) were female. Male patients had a higher median age (59 vs 50 years, P = 0.004), greater rates of dyslipidaemia (34% vs 20.2%, P = 0.025), a lower ejection fraction (55% vs 57%, P = 0.046) and longer cross-clamp (77 vs 67.50 min, P = 0.004) and circulatory arrest times (42 vs 37.50 min, P = 0.007). No difference was observed in unadjusted 2-year survival after PTE between patients stratified by race and sex (P = 0.35). After adjustment for clinically relevant variables, neither socioeconomic status, sex nor race were associated with mortality in Cox proportional hazard analysis. CONCLUSIONS: Sex, socioeconomic status and race were not associated with adverse outcomes after PTE in our single-centre experience.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Pulmonary Thromboendarterectomy in Chronic Thromboembolic Pulmonary Hypertension: A Report of 15 Cases
    Sadeghi, H. A.
    Omrani, G. R.
    Peyghambari, M. M.
    Shojaeifar, M.
    Basiri, H. A.
    Azarnik, H.
    Bakhshandeh, H.
    IRANIAN HEART JOURNAL, 2010, 11 (02): : 44 - 48
  • [32] Mid term results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension
    Mayer, E
    Dahm, M
    Hake, U
    Schmid, FX
    Pitton, M
    Kupferwasser, I
    Iversen, S
    Oelert, H
    ANNALS OF THORACIC SURGERY, 1996, 61 (06): : 1788 - 1792
  • [33] Histopathological Evaluation of Pulmonary Thromboendarterectomy Specimens of Chronic Thromboembolic Pulmonary Hypertension
    Obikane, Hiyo
    Shimodai-Yamada, Sayaka
    Koizumi, Nobusato
    Ogino, Hitoshi
    Nagao, Toshitaka
    Hao, Hiroyuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (11) : 1661 - 1673
  • [34] Chronic thromboembolic pulmonary hypertension: surgical treatment with thromboendarterectomy
    Antonio Blazquez, Jose
    Escribano, Pilar
    Perez, Enrique
    Jesus Lopez, Maria
    Angel Gomez, Miguel
    Maria Cortina, Jose
    ARCHIVOS DE BRONCONEUMOLOGIA, 2009, 45 (10): : 496 - 501
  • [35] Tricuspid Surgery and Pulmonary Thromboendarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension
    Golts, E. M.
    Aoki, K. C.
    Afshar, K.
    Bigbee, J. M.
    Madani, M. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S507 - S507
  • [36] Epoprostenol therapy as a bridge to pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension
    Kerr, KM
    Rubin, LJ
    CHEST, 2003, 123 (02) : 319 - 320
  • [37] Mortality in Chronic Thromboembolic Pulmonary Hypertension Patients with Residual Pulmonary Hypertension Post Pulmonary Thromboendarterectomy
    Jensen, K. W.
    Kerr, K. M.
    Fedullo, P. F.
    Kim, N. H.
    Test, V. J.
    Auger, W. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [38] Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: Effects before and after pulmonary thromboendarterectomy
    Kramm, T
    Eberle, B
    Krummenauer, F
    Guth, S
    Oelert, H
    Mayer, E
    ANNALS OF THORACIC SURGERY, 2003, 76 (03): : 711 - 718
  • [39] Assessment of left atrial volume before and after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension
    Marston, Nicholas A.
    Auger, William R.
    Madani, Michael M.
    Kimura, Bruce J.
    Strachan, G. Monet
    Raisinghani, Ajit B.
    DeMaria, Anthony N.
    Blanchard, Daniel G.
    CARDIOVASCULAR ULTRASOUND, 2014, 12
  • [40] Mechanism of improved exercise capacity after pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension
    Iwase, T
    Nagaya, F
    Sakamaki, F
    Kyotani, S
    Goto, Y
    Nakanishi, N
    CIRCULATION, 1999, 100 (18) : 588 - 588